Veeda Clinical Research Limited

The latest issue is out! Read the Veeda Newsletter November 2024 Edition here - https://bit.ly/3CR2KvP Partners in creating a healthier tomorrow. Heads BIONEEDS INDIA PRIVATE LIMITED #Veeda #VeedaClinicalResearch #Newsletter #NovemberNewsletter #November2024 #VeedaNewsletter #TheVeedaNewsletter

At Veeda, we prioritize the safety and security of our data and operations. To strengthen our defenses, we have implemented comprehensive cybersecurity awareness training for all our employees. As part of this initiative, Veeda Group employees at its preclinical and biopharma sites at Bengaluru (India) underwent the cybersecurity awareness training. This initiative is designed to foster a culture of vigilance and proactive security measures. By educating our team on the latest cyber threats and best practices, we ensure that everyone at Veeda is equipped to identify and mitigate potential risks. Our commitment to cybersecurity not only protects our valuable data but also reinforces our dedication to maintaining the highest standards of integrity and trust. Join us in our mission to create a safer digital work environment. #VeedaGroup #ClinicalResearch #PharmaResearch #CyberSecurity #CyberAwareness #Veeda #DataProtection #CyberVigilance Sanjib Banerjee, PhD BIONEEDS INDIA PRIVATE LIMITED Heads

At the CPHI & PMEC India 2024, Veeda Group had the privilege of engaging with leading figures in the pharmaceutical industry. Our Group CEO and MD, Dr. Mahesh Bhalgat participated in dynamic discussions, sharing insights on cutting-edge trends and innovations. The interactions were incredibly enriching, fostering new ideas and potential collaborations. The leaders shared their views on the theme of "Seizing New Frontiers: Uncloking India's Potential Amidst Global Shifts" and the discussion was focused on capitalizing on geo-political shift, technology and innovation, tackling infrastructure and regulatory challenges, collaborative growth strategies, drug biotransformation and driving pharma sustainability. Veeda Group is inspired by the expertise and enthusiasm of the attendees, which made the event a remarkable experience. Veeda is excited to build on these connections and continue driving progress in the pharma and biotech sector. We look forward to continuing these conversations and exploring new collaborations. Rhonda Duffy Shyamakant Giri Aditi Kare Panandikar Sridevi Khambhampaty Gopal Agrawal Deepak Sapra Satish Wagh Parag Swadia Harish K Jain Namit Joshi BAFNA MAHAVEER Sanchit Nanda Nikhil Chopra Chakravarthi AVPS Prashant Sharma Poorvank P. Yugal Sikri Prashant Nagre Rajiv Nath Gagan Sharma Dr. Pavan Bhat, MBA kaushik desai Shankar Gupta Pushpa Vijayaraghavan Sriram Shrinivasan CPHI CPhI Conferences Usha Sharma Heads BIONEEDS INDIA PRIVATE LIMITED

Our bioanalytical solutions support you in method development, method validation, and sample analysis. So far, we have 1260+ available bioanalytical methods, which include generics, complex generics, NCEs, and large molecule assays.   View our latest assay list here - https://lnkd.in/dVDnkqDA.   To know more, visit www.veedacr.com or write to us at info@veedacr.com   Partners in creating a healthier tomorrow Heads BIONEEDS INDIA PRIVATE LIMITED #VeedaGroup #VeedaCR #AssayList #BioanalyticalSolutions #ClinicalResearch #BioanalyticalMethods

Hurry Up! Registration for Our Biosimilar Webinar is Now Open! We are thrilled to announce that registration is now live for this insightful webinar, designed specifically for professionals in biosimilar development. Don’t miss this opportunity to explore advanced analytical techniques and gain valuable insights into achieving biosimilarity with precision and compliance. Webinar Details: - Title: Advanced Analytical Characterization Techniques for Biopharmaceutical Development: Establishing Biosimilarity! - Date: 12th December 2024 - Time: 18:30 IST | 14:00 CET | 08:00 EST - Duration: 60 minutes - Platform: Zoom Why Attend? - Gain insights into Biosimilar Development & Regulatory Pathways - Learn how to leverage HRMS for Molecular Characterization - Understand Higher Order Structure (HOS) Assessment - Discover strategies for Overcoming Analytical Challenges in complex biopharmaceuticals Secure your spot now! Register Now: https://lnkd.in/dt5Zx2UV Heads BIONEEDS INDIA PRIVATE LIMITED Partners in creating a healthier tomorrow #Biosimilars #Webinar #AnalyticalCharacterization #Biopharma #Biosimilarity #PharmaWebinar #VeedaGroup #Biotechnology

Wishing all our colleagues, clients, friends, and partners a Thanksgiving filled with joy, gratitude, and abundant blessings. May this season bring you happiness, warmth, and the fulfillment of cherished moments with your loved ones! Partners in creating a healthier tomorrow. Heads BIONEEDS INDIA PRIVATE LIMITED #Veeda #VeedaGroup #HappyThanksgiving #Thanksgiving2024

Day 1 of CPHI & PMEC India 2024 witnessed an exciting and interactive conversation between the industry experts and doyens of pharmaceutical industry. Moderating the leadership panel discussion, titled - 𝗖𝗼𝗻𝘁𝗶𝗻𝘂𝗼𝘂𝘀 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 & 𝗔𝗴𝗶𝗹𝗲 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 - Dr. Mahesh Bhalgat, Group CEO & MD of Veeda Clinical Research Limited discussed key trends with eminent industry experts: 1. Atul Shastri, President Operations, Eugia Pharma Specialities Ltd 2. Tathagata Dutta, PhD, President & Chief Technology Officer, Jodas Expoim Pvt. Ltd. 3. Abhay Kumar Srivastava, President Operations, MANKIND PHARMA LTD 4. Prof. V. Ravichandiran, Vice Chancellor, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi and 5. Mr. Yugal Sikri, Managing Director, RPG Life Sciences Ltd. The panel discussion featured conversation on the importance of sustained investment in R&D to drive breakthroughs in therapeutic technologies and the role of partnerships between academia, industry, and government in fostering innovation. Panellists also shared views and case studies on how agile manufacturing allows for rapid scaling of production in response to demand fluctuations and shared examples of how this flexibility has been crucial during public health emergencies, such as the COVID-19 pandemic. The panellist members also expressed views and shared their experiences on the integration of continuous innovation with agile manufacturing to create end-to-end solutions for therapeutic development and touched upon the environmental and economic benefits of combining innovative research with agile manufacturing. https://lnkd.in/gttdupwt #AtTheHeartOfPharma #CPHIAndPMECIndia2024 #PharmaInnovation #AgileManufacturing #LeadershipPanel #FutureOfTherapeutics   CPhI Conferences CPHI Express Pharma BioSpectrum India BioVoice News BioProcess International Contract Pharma Vikas Dandekar ET Pharma

Veeda conducted ISO 17025 training for its employees at biopharma site at Peenya (Bengaluru). Mr. Natarajan G. from ExcelR Solutions conducted the 2-day ISO/IEC 17025:2017 awareness training, which was aimed to enhance understanding of the ISO/IEC 17025:2017 standard that outlines general requirements for the competence of testing and calibration laboratories at Veeda Biopharma. Senior management team members including employees from clinical bioanalysis, analytical and characterization, training and development and quality assurance teams underwent sessions related to Laboratory Management System (LMS) including other core topics of sample management, quality assurance, inventory management, regulatory compliance, legal requirements and collaborations. Dr. Mahesh Bhalgat, Group CEO and MD, also interacted with the participants acknowledging the collaborative effort of all participants showcasing commitment to professional development and enhancement of business performance and continuity. Catch the glimpse of the 2-day training session, conducted by the Training & Development team at Veeda.   Sanjib Banerjee, PhD Jagadeesh Boda, Ph.D. Rajiv Bharadwaj, Ph.D Dr. Swaroop Sarkar Parag K. Patel Sameer pasha Shruthi G S Saumen Saha, Ph.D. Nandan L ASWATHI M VARIER Mithilesh Kumar Dileepkumar P V, PhD Gagana S M Lokesha M M Devangi Dave Rachana Shah HARDIK PATEL BIONEEDS INDIA PRIVATE LIMITED

Veeda’s biopharma site at Peenya (Bengaluru) secures the coveted CDSCO certification from the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India (GoI). The CDSCO certification to Veeda’s biopharma division is a hallmark of compliance that guarantees high standards of quality in research practices. This regulatory approval establishes Veeda’s authority in maintaining the integrity and safety of the research process, which is essential for producing reliable results. Veeda's Biopharma Division offers a comprehensive range of services to support biotherapeutic drug development. Veeda biopharma’s CDSCO approval has significantly enhanced the credibility of laboratory operations at Peenya (Bengaluru) site. The regulatory approval is a testament of Veeda adhering to stringent quality control measures ensuring that all testing and research activities meet high standards of accuracy and reliability. Veeda’s laboratories follow standardized procedures for testing and analysis, which helps in maintaining consistency and reproducibility of results. The implementation of robust safety protocols at laboratories helps Veeda protect both - the integrity of the samples being tested and the laboratory personnel. The CDSCO certification to biopharma laboratories has also enhanced the credibility of Veeda, making it more attractive to clients and partners, who require assurance of regulatory compliance and high-quality standards. This will propel Veeda to easily participate in national and international research projects and collaborations, expanding its market reach and opportunities.  Veeda offers cutting-edge solutions for clinical bioanalysis that delivers comprehensive bioanalytical services for early and late-phase clinical trials, ensuring accurate and efficient analysis through advanced technology and rigorous quality assurance. Sanjib Banerjee, PhD Sivakumar Vaidyanathan Kiran Marthak Parag K. Patel Heads Amee Kanuga Pranav Dalal Jagadeesh Boda, Ph.D. BIONEEDS INDIA PRIVATE LIMITED Ministry of Health & Family Welfare, Government of India

Join us for an insightful webinar on Advanced Analytical Characterization Techniques for Biopharmaceutical Development: Establishing Biosimilarity! Date: 12 December 2024 Time: 18:30 IST | 14:00 CET | 08:00 EST Our expert speakers, Dr. Nandeesha N P and Dr. Saumen Saha, Ph.D., will delve into key strategies and techniques essential for biosimilar development, from molecular characterization to regulatory approval. Don’t miss this opportunity to learn from real-world case studies and explore emerging technologies in biopharmaceuticals! Key Takeaways: ✅ Biosimilar development & Regulatory insights ✅ HRMS for Molecular Characterization ✅ Higher Order Structure (HOS) Assessment ✅ Overcoming analytical challenges in Complex biopharmaceuticals Register now! https://lnkd.in/dt5Zx2UV Heads BIONEEDS INDIA PRIVATE LIMITED To know more about us, visit www.veedacr.com or write to us at info@veedacr.com. Partners in creating a healthier tomorrow. #Webinar #Biopharmaceuticals #Biosimilars #AnalyticalCharacterization #Biotech #HRMS #PharmaDevelopment #HigherOrderStructure #Biosimilarity #EmergingTechnologies #VeedaGroup #DrugDevelopment #PharmaInnovation #PharmaResearch